More tools:Markets·Screener·Research·Chat

Vivos Therapeutics, Inc. Common Stock (VVOS) Financial Statements

Vivos Therapeutics, Inc. Common Stock
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG00H1NZV85
XNAS · usd
0.18▼ 0.01 (-3.59%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close0.19
Day's Range0.17 – 0.19
52-Week Range0.16 – 4.13
Volume5.0M
Avg Volume20.5M
Share Statistics
Shares Outstanding
Employees268
ExchangeXNAS
Listed2020-12-11
Share count as of August 13, 2026
Loading Income Statement…
Key questions about Vivos Therapeutics, Inc. Common Stock (VVOS)
What is Vivos Therapeutics, Inc. Common Stock's Market Cap?
Vivos Therapeutics, Inc. Common Stock's Market Cap is $3.6M, based on as-reported figures from SEC (XBRL) filings.
What is Vivos Therapeutics, Inc. Common Stock's Enterprise Value?
Vivos Therapeutics, Inc. Common Stock's Enterprise Value is $10.1M, based on as-reported figures from SEC (XBRL) filings.
What is Vivos Therapeutics, Inc. Common Stock's Price / Sales?
Vivos Therapeutics, Inc. Common Stock's Price / Sales is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Vivos Therapeutics, Inc. Common Stock's EV / Revenue?
Vivos Therapeutics, Inc. Common Stock's EV / Revenue is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is Vivos Therapeutics, Inc. Common Stock's EV / EBITDA?
Vivos Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Vivos Therapeutics, Inc. Common Stock's Revenue (TTM)?
Vivos Therapeutics, Inc. Common Stock's Revenue (TTM) is $20.9M, based on as-reported figures from SEC (XBRL) filings.
What is Vivos Therapeutics, Inc. Common Stock's Net Income (TTM)?
Vivos Therapeutics, Inc. Common Stock's Net Income (TTM) is -$25.5M, based on as-reported figures from SEC (XBRL) filings.
What is Vivos Therapeutics, Inc. Common Stock's EBITDA?
Vivos Therapeutics, Inc. Common Stock's EBITDA is -$20.8M, based on as-reported figures from SEC (XBRL) filings.
What is Vivos Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?
Vivos Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.27, based on as-reported figures from SEC (XBRL) filings.
What is Vivos Therapeutics, Inc. Common Stock's EBITDA Margin?
Vivos Therapeutics, Inc. Common Stock's EBITDA Margin is -99.3%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
Revenue
YoY growth+34.9%+70.5%+3.4%+75.7%
Cost of Revenue
Gross profit
% of revenue57.3%59.5%78.1%58.0%
Operating expenses
Selling, General and Administrative Expense
Depreciation Expense
Total operating expenses
% of revenue150.9%188.2%245.0%127.8%
Operating loss
% of revenue-93.6%-128.7%-166.9%-69.8%
Non-operating income (expense)
Non-Operating Income (Expense)
Other Income
Loss before income taxes
Net loss
% of revenue-107.2%-150.8%-181.9%-79.6%
Net Income Attributable to Noncontrolling Interest——
Net loss attributable to stockholders——
% of revenue-106.4%-149.4%——
Earnings Per Share (Basic)
Earnings Per Share (Diluted)